Visit us to experience the power of the Parsortix® PC1 system, our unique FDA cleared, and CE marked circulating tumor cell (CTC) enrichment technology.
Latest report
Annual Report December 2023
Please click the links below to download our Annual and Interim Reports and Financial Statements
Open PDFFor any investor relations queries please contact
investor@angleplc.comFor any investor relations queries please contact
investor@angleplc.comVisit us to experience the power of the Parsortix® PC1 system, our unique FDA cleared, and CE marked circulating tumor cell (CTC) enrichment technology.